Avadel’s LiquiTime research and development services employ the competitive advantages of its Micropump® technology to allow development of modified/controlled release liquid suspension formulations. Avadel’s LiquiTime services focus on products particularly suitable for dosing children and other patients having issues swallowing tablets or capsules. Unlike the development of resin-complex-based liquid pharmaceuticals, Avadel’s LiquiTime research/development services employ technologies that are not limited to ionic drugs and can be applied to the development of combination products.
Advantages of LiquiTime-developed products:
- Easy-to-swallow formulations
- Good mouthfeel
- Dosing flexibility